Novo and Anthropic partner to test Claude Science AI platform in drug discovery R&D
read at Endpoints ↗DealPositive
Novo, the Danish pharmaceutical company, announced a partnership with AI firm Anthropic.
The collaboration will focus on evaluating Anthropic’s Claude Science AI model within Novo’s research and development pipelines to aid drug discovery.
The agreement highlights Anthropic’s expanding role in the life-sciences sector and deepens its ties with Novo.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Novo signs Anthropic deal to test Claude Science in R&D”
read at Endpoints ↗88 words · retrieved 2h ago
comments(0)
5-min edit window · permanent after that